BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23038012)

  • 1. Effects of Hsp90 inhibitors, geldanamycin and its analog, on ceramide metabolism and cytotoxicity in PC12 cells.
    Toyomura K; Saito T; Emori S; Matsumoto I; Kato E; Kaneko M; Okuma Y; Nakamura H; Murayama T
    J Toxicol Sci; 2012; 37(5):1049-57. PubMed ID: 23038012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of oxidative stress in geldanamycin-induced cytotoxicity and disruption of Hsp90 signaling complex.
    Clark CB; Rane MJ; El Mehdi D; Miller CJ; Sachleben LR; Gozal E
    Free Radic Biol Med; 2009 Nov; 47(10):1440-9. PubMed ID: 19703551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of ceramidase and ceramide kinase by vanadate via a tyrosine kinase-mediated pathway.
    Tada E; Toyomura K; Nakamura H; Sasaki H; Saito T; Kaneko M; Okuma Y; Murayama T
    J Pharmacol Sci; 2010; 114(4):420-32. PubMed ID: 21127389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geldanamycin and its analog induce cytotoxicity in cultured human retinal pigment epithelial cells.
    Wu WC; Wu MH; Chang YC; Hsieh MC; Wu HJ; Cheng KC; Lai YH; Kao YH
    Exp Eye Res; 2010 Aug; 91(2):211-9. PubMed ID: 20493187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newly synthetic ceramide-1-phosphate analogs; their uptake, intracellular localization, and roles as an inhibitor of cytosolic phospholipase A(2)α and inducer of cell toxicity.
    Makiyama T; Nagasaka N; Houjyo Y; Yamaura E; Nakamura H; Koide Y; Nishida A; Murayama T
    Biochem Pharmacol; 2010 Nov; 80(9):1396-406. PubMed ID: 20688048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trafficking of Acetyl-C16-Ceramide-NBD with Long-Term Stability and No Cytotoxicity into the Golgi Complex.
    Makiyama T; Nakamura H; Nagasaka N; Yamashita H; Honda T; Yamaguchi N; Nishida A; Murayama T
    Traffic; 2015 May; 16(5):476-92. PubMed ID: 25615589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of geldanamycin analogs against human cancer cells.
    Li YP; Chen JJ; Shen JJ; Cui J; Wu LZ; Wang Z; Li ZR
    Cancer Chemother Pharmacol; 2015 Apr; 75(4):773-82. PubMed ID: 25681003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsp90 inhibitor geldanamycin attenuates the cytotoxicity of sunitinib in cardiomyocytes via inhibition of the autophagy pathway.
    Kimura T; Uesugi M; Takase K; Miyamoto N; Sawada K
    Toxicol Appl Pharmacol; 2017 Aug; 329():282-292. PubMed ID: 28624441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells.
    Lin K; Rockliffe N; Johnson GG; Sherrington PD; Pettitt AR
    Oncogene; 2008 Apr; 27(17):2445-55. PubMed ID: 17982489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of heterotrimeric Galpha(o) subunits via the proteosome pathway is induced by the hsp90-specific compound geldanamycin.
    Busconi L; Guan J; Denker BM
    J Biol Chem; 2000 Jan; 275(3):1565-9. PubMed ID: 10636845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geldanamycin, an inhibitor of Hsp90, potentiates cytochrome P4502E1-mediated toxicity in HepG2 cells.
    Dey A; Cederbaum AI
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1391-9. PubMed ID: 16513847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp90 Inhibition Reduces TLR5 Surface Expression and NF-
    Na BH; Hoang TX; Kim JY
    Biomed Res Int; 2018; 2018():4319369. PubMed ID: 29651431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radicicol but not geldanamycin evokes oxidative stress response and efflux protein inhibition in ARPE-19 human retinal pigment epithelial cells.
    Ryhänen T; Mannermaa E; Oksala N; Viiri J; Paimela T; Salminen A; Atalay M; Kaarniranta K
    Eur J Pharmacol; 2008 Apr; 584(2-3):229-36. PubMed ID: 18313664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct regulation of insulin receptor substrate-1 and -2 by 90-kDa heat-shock protein in adrenal chromaffin cells.
    Yoshikawa N; Nemoto T; Satoh S; Maruta T; Yanagita T; Chosa E; Wada A
    Neurochem Int; 2010 Jan; 56(1):42-50. PubMed ID: 19737590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells.
    Higashi C; Saji C; Yamada K; Kagawa H; Ohga R; Taira T; Fujimuro M
    Biol Pharm Bull; 2012; 35(5):725-30. PubMed ID: 22687408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite effects of the Hsp90 inhibitor Geldanamycin: induction of apoptosis in PC12, and differentiation in N2A cells.
    López-Maderuelo MD; Fernández-Renart M; Moratilla C; Renart J
    FEBS Lett; 2001 Feb; 490(1-2):23-7. PubMed ID: 11172804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity.
    Bisht KS; Bradbury CM; Mattson D; Kaushal A; Sowers A; Markovina S; Ortiz KL; Sieck LK; Isaacs JS; Brechbiel MW; Mitchell JB; Neckers LM; Gius D
    Cancer Res; 2003 Dec; 63(24):8984-95. PubMed ID: 14695217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis caused by Hsp90 inhibitor geldanamycin in Leishmania donovani during promastigote-to-amastigote transformation stage.
    Li Q; Zhou Y; Yao C; Ma X; Wang L; Xu W; Wang Z; Qiao Z
    Parasitol Res; 2009 Nov; 105(6):1539-48. PubMed ID: 19690889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine-phosphorylation and activation of glucosylceramide synthase by v-Src: Its role in survival of HeLa cells against ceramide.
    Honda T; Motoyoshi K; Kasahara J; Yamagata K; Takahashi H; Nakamura H; Murayama T
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jan; 1866(1):158817. PubMed ID: 32980536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the EF-2 kinase/Hsp90 protein complex: a possible mechanism to inhibit glioblastoma by geldanamycin.
    Yang J; Yang JM; Iannone M; Shih WJ; Lin Y; Hait WN
    Cancer Res; 2001 May; 61(10):4010-6. PubMed ID: 11358819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.